Any pathology product (like pharmaceuticals) must have demonstrated its efficacy before it can be sold.
Without such a demonstration its unsaleable.
The USA Food and Drug Administration (FDA) is the pre-eminent approval authority.
If approval for a product is obtained through the FDA then approvals elsewhere will be much easier to obtain. It's like dominoes, knock one over and the rest will follow.
I agree it's frustrating, because it's time consuming, but, like any company in the medical field nothing seems to be happening until approval is gained.
Then there'll be movement at the station.
- Forums
- ASX - By Stock
- LBT
- Ann: LBT begins key U.S. trial of APAS technology
Ann: LBT begins key U.S. trial of APAS technology, page-38
Featured News
Add LBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.13M |
Open | High | Low | Value | Volume |
1.3¢ | 1.4¢ | 1.3¢ | $10.09K | 728.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 4745520 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 418800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 4745520 | 0.013 |
4 | 7533332 | 0.012 |
7 | 860500 | 0.011 |
7 | 1289004 | 0.010 |
3 | 256759 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 418800 | 1 |
0.015 | 530651 | 5 |
0.016 | 638296 | 4 |
0.017 | 958881 | 6 |
0.018 | 457000 | 3 |
Last trade - 12.59pm 18/09/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |